cinnamtannin A2: a tetrameric proanthcyanidin; isolated from cacao products; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
cinnamtannin A2 : A proanthocyanidin isolated from Cinnamomum cassia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 16130899 |
| CHEMBL ID | 3409094 |
| CHEBI ID | 81227 |
| SCHEMBL ID | 6861829 |
| MeSH ID | M0386843 |
| Synonym |
|---|
| (2r,2'r,2''r,2'''r,3r,3'r,3''r,3'''r,4r,4's,4''s)-2,2',2'',2'''-tetrakis(3,4-dihydroxyphenyl)-3,3',3'',3''',4,4',4'',4'''-octahydro-2h,2'h,2''h,2'''h-4,8':4',8'':4'',8'''-quaterchromene-3,3',3'',3''',5,5',5'',5''',7,7',7'',7'''-dodecol |
| tetrameric proanthocyanidin |
| (2r,3r,4r)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-8-yl]-3,5,7-trihydroxy-chroman-8-yl]-8-[(2r,3r,4r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-yl]chromane-3,5,7-tr |
| cinnamtannin a2 |
| C17625 |
| SCHEMBL6861829 |
| CHEBI:81227 , |
| (1(2)r,1(3)r,1(4)r,2(2)r,2(3)r,2(4)r,3(2)r,3(3)r,3(4)s,4(2)r,4(3)r)-1(2),2(2),3(2),4(2)-tetrakis(3,4-dihydroxyphenyl)-1(3),1(4),2(3),2(4),3(3),3(4),4(3),4(4)-octahydro-1(2)h,2(2)h,3(2)h,4(2)2h-[1(4),2(8):2(4),3(8):3(4),4(8)-quater-1-benzopyran]-1(3),1(5), |
| procyanidin tetramer |
| (2r,3r,4r)-2-(3,4-dihydroxyphenyl)-8-[(2r,3r,4r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-4-[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-3,5,7-t |
| CHEMBL3409094 |
| [epicatechin(4b->8)]3-epicatechin |
| cinnamtannin i |
| epicatechin tetramer |
| 86631-38-1 |
| (2r,3r,4r)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-chromen-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2h-chromen-8-yl]-8-[(2r,3r,4r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy- |
| Q23048725 |
| [4,8':4',8'':4'',8'''-quater-2h-1-benzopyran]-3,3',3'',3''',5,5',5'',5''',7,7',7'',7'''-dodecol, 2,2',2'',2'''-tetrakis(3,4-dihydroxyphenyl)-3,3',3'',3''',4,4',4'',4'''-octahydro-, (2r,2'r,2''r,2'''r,3r,3'r,3''r,3'''r,4r,4'r,4''s)- |
| E88997 |
| DTXSID201317088 |
| CS-0198420 |
| HY-N9536 |
| AKOS040758406 |
| Role | Description |
|---|---|
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| proanthocyanidin | A flavonoid oligomer obtained by the the condensation of two or more units of hydroxyflavans. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1197348 | Antioxidant activity assessed as DPPH radical scavenging activity | 2015 | European journal of medicinal chemistry, Mar-06, Volume: 92 | Medicinal uses, phytochemistry and pharmacology of family Sterculiaceae: a review. |
| AID1197347 | Antioxidant activity assessed as inhibition of linoleic acid autooxidation | 2015 | European journal of medicinal chemistry, Mar-06, Volume: 92 | Medicinal uses, phytochemistry and pharmacology of family Sterculiaceae: a review. |
| AID1197346 | Antioxidant activity in rat liver microsomes assessed as inhibition of NADPH-dependent lipid peroxidation | 2015 | European journal of medicinal chemistry, Mar-06, Volume: 92 | Medicinal uses, phytochemistry and pharmacology of family Sterculiaceae: a review. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.49) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||